One drug, two Prices: Understanding the Role of Pharmacy Benefit Managers in US Drug Pricing
Mar 07, 2023
Humira, a top-selling drug with $200 billion in revenue over two decades, recently lost its patent monopoly. This paved the way for biosimilars like Amjevita to...